Investors

Announcements

Result of General Meeting

31 May 2023

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that resolutions 1 - 7 of the Requisition Resolutions put to shareholders at the requisitioned General Meeting, proposed by the Named Shareholders, held today were defeated.

Resolution 8, relating to the re-convening of the adjourned 2022 Annual General Meeting, was passed.  It is the Company's intention to shortly re-convene the 2022 Annual General Meeting.

The results of the poll voting (which includes votes submitted by proxy) are detailed below and will be available shortly on the Company's website: http://truspine.org/


Resolution For % Against % Total Withheld*
1. Norman Alec Charles Lott be and is hereby removed from the office of director of the Company with immediate effect. 43,257,869 47.54% 47,731,826 52.46% 90,989,695 -
2. Nikunj Kantilal Patel be and is hereby removed from the office of director of the Company with immediate effect. 25,932,069 28.50%  65,057,626 71.50% 90,989,695 -
3. Annabel Martha Schild be and is hereby removed from the office of director of the Company with immediate effect. 27,498,122 30.22% 63,491,573 69.78% 90,989,695 -
4. Laurence Richard Strauss be and is hereby removed from the office of director of the Company with immediate effect. 42,086,200 45.85% 49,703,494 54.15% 91,789,694 -
5. Todd Michael Cramer, having indicated his willingness to act, be and is hereby appointed a director of the Company with immediate effect. 26,051,848 30.61% 59,050,608 69.39% 85,102,456 5,887,239
6. Peter Houghton, having indicated his willingness to act, be and is hereby appointed a director of the Company with immediate effect. 26,035,182 30.59% 59,067,275 69.41% 85,102,457 5,887,238
7. Anthony Swoboda, having indicated his willingness to act, be and is hereby appointed a director of the Company with immediate effect. 37,515,629 44.08% 47,586,828 55.92% 85,102,457 5,887,238
8. The adjourned 2022 Annual General Meeting be re-convened as soon as reasonably practical. 44,630,331 52.51% 40,358,125 47.49% 84,988,456 6,001,239

Capitalised terms used in this announcement have the meanings given to them in the circular published on 5 May 2023, unless the context provides otherwise

TruSpine CEO Laurence Strauss commented: "I am pleased to report that all but one of the resolutions tabled by certain shareholders for today's requisitioned General Meeting have been defeated. I hope that as a company we can now draw a line under this matter and move forward so that we can take the necessary steps to realise the potential of our unique product portfolio. I look forward to reporting our progress to shareholders in due course.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.

Enquiries:

TruSpine Technologies Plc

Tel: +44 (0)20 7118 0852

Laurence Strauss, Chief Executive Officer


Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti


Oberon Capital (Joint Broker)

 Tel: +44 (0)20 3179 5300

Mike Seabrook / Chris Crawford


Peterhouse Capital Limited (Joint Broker & Financial Adviser)

 Tel: +44 (0)20 7469 0930

Lucy Williams / Duncan Vasey


Novus Communications (PR and IR)

Tel: +44 (0)20 7448 9839

Alan Green / Jacqueline Briscoe

[email protected]